PAPER Wagner MT, Bachman DL, Spicer KM
SEARCH RESULTS
330921 RESULTS
PAPER Hepp DH, Ruiter AM, Galis Y, Voorn P, Rozemuller AJ, Berendse HW, Foncke EM, van de Berg WD
Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients.
J Neuropathol Exp Neurol. 2013 Dec;72(12):1162-70. PubMed: 24226265PAPER Jarero-Basulto JJ, Luna-Muñoz J, Mena R, Kristofikova Z, Ripova D, Perry G, Binder LI, Garcia-Sierra F
Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease.
J Neuropathol Exp Neurol. 2013 Dec;72(12):1145-61. PubMed: 24226268PAPER Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Martí MJ, Clarimón J, Lleó A
Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
J Neuropathol Exp Neurol. 2013 Dec;72(12):1203-12. PubMed: 24226269PAPER Serrano-Pozo A, Qian J, Monsell SE, Frosch MP, Betensky RA, Hyman BT
Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.
J Neuropathol Exp Neurol. 2013 Dec;72(12):1182-92. PubMed: 24226270PAPER Tabuchi H, Konishi M, Saito N, Kato M, Mimura M
Reverse Fox test for detecting visuospatial dysfunction corresponding to parietal hypoperfusion in mild Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):177-82. Epub 2013 Nov 12 PubMed: 24226465PAPER Beck IR, Schmid NS, Berres M, Monsch AU
Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression.
Int J Geriatr Psychiatry. 2014 Jun;29(6):624-34. Epub 2013 Nov 14 PubMed: 24227657PAPER Beason-Held LL, Goh JO, An Y, Kraut MA, O'Brien RJ, Ferrucci L, Resnick SM
Changes in brain function occur years before the onset of cognitive impairment.
J Neurosci. 2013 Nov 13;33(46):18008-14. PubMed: 24227712PAPER Mellone M, Kestoras D, Andrews MR, Dassie E, Crowther RA, Stokin GB, Tinsley J, Horne G, Goedert M, Tolkovsky AM, Spillantini MG
Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies.
J Neurosci. 2013 Nov 13;33(46):18175-89. PubMed: 24227726PAPER Molloy B, McMahon HE
A cell-biased effect of estrogen in prion infection.
J Virol. 2014 Jan;88(2):1342-53. Epub 2013 Nov 13 PubMed: 24227845PAPER Marciniuk K, Taschuk R, Napper S
Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy.
Clin Dev Immunol. 2013;2013:473706. Epub 2013 Oct 20 PubMed: 24228054PAPER Janicki SC, Cosentino S, Louis ED
The cognitive side of essential tremor: what are the therapeutic implications?
Ther Adv Neurol Disord. 2013 Nov;6(6):353-68. PubMed: 24228071PAPER Bonini SA, Ferrari-Toninelli G, Montinaro M, Memo M
Notch signalling in adult neurons: a potential target for microtubule stabilization.
Ther Adv Neurol Disord. 2013 Nov;6(6):375-85. PubMed: 24228073PAPER Majláth Z, Tajti J, Vécsei L
Kynurenines and other novel therapeutic strategies in the treatment of dementia.
Ther Adv Neurol Disord. 2013 Nov;6(6):386-97. PubMed: 24228074PAPER Donix M, Scharf M, Marschner K, Werner A, Sauer C, Gerner A, Nees JA, Meyer S, Donix KL, von Kummer R, Holthoff VA
Cardiovascular risk and hippocampal thickness in Alzheimer's disease.
Int J Alzheimers Dis. 2013;2013:108021. PubMed: 24228185Current Filters
No filters selected